| Aardvark Therapeutics, Inc. |
10%+ Owner |
Common Stock |
2,050,902 |
|
|
14 Feb 2025 |
By Vickers Venture Fund VI Pte. Ltd. |
| Vickers Vantage Corp. I |
Other*, 10%+ Owner |
Warrants |
901,000 |
|
|
10 Nov 2022 |
By Vickers Venture Fund VI Pte Ltd |
| Vickers Vantage Corp. I |
Other*, 10%+ Owner |
Warrants |
99,000 |
|
|
10 Nov 2022 |
By Vickeres Venture Fund VI (Plan) Pte Ltd |
| Aardvark Therapeutics, Inc. |
10%+ Owner |
Series A Convertible Preferred Stock |
0 |
|
|
14 Feb 2025 |
By Vickers Venture Fund VI Pte. Ltd. |
| Aardvark Therapeutics, Inc. |
10%+ Owner |
Series B Convertible Preferred Stock |
0 |
|
|
14 Feb 2025 |
By Vickers Venture Fund VI Pte. Ltd. |